Literature DB >> 32194129

Long-term effects of psychedelic drugs: A systematic review.

Jacob S Aday1, Cayla M Mitzkovitz2, Emily K Bloesch2, Christopher C Davoli2, Alan K Davis3.   

Abstract

Research into the basic effects and therapeutic applications of psychedelic drugs has grown considerably in recent years. Yet, pressing questions remain regarding the substances' lasting effects. Although individual studies have begun monitoring sustained changes, no study to-date has synthesized this information. Therefore, this systematic review aims to fill this important gap in the literature by synthesizing results from 34 contemporary experimental studies which included classic psychedelics, human subjects, and follow-up latencies of at least two weeks. The bulk of this work was published in the last five years, with psilocybin being the most frequently administered drug. Enduring changes in personality/attitudes, depression, spirituality, anxiety, wellbeing, substance misuse, meditative practices, and mindfulness were documented. Mystical experiences, connectedness, emotional breakthrough, and increased neural entropy were related to these long-term changes in psychological functioning. Finally, with proper screening, preparation, supervision, and integration, limited aversive side effects were noted by study participants. Future researchers should focus on including larger and more diverse samples, lengthier longitudinal designs, stronger control conditions, and standardized dosages.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Long-term; Psychedelic drugs; Psychedelics; Review

Mesh:

Substances:

Year:  2020        PMID: 32194129     DOI: 10.1016/j.neubiorev.2020.03.017

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  14 in total

Review 1.  Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.

Authors:  Jacob S Aday; Boris D Heifets; Steven D Pratscher; Ellen Bradley; Raymond Rosen; Joshua D Woolley
Journal:  Psychopharmacology (Berl)       Date:  2022-04-01       Impact factor: 4.530

Review 2.  Defining Transformative Experiences: A Conceptual Analysis.

Authors:  Alice Chirico; Marta Pizzolante; Alexandra Kitson; Elena Gianotti; Bernhard E Riecke; Andrea Gaggioli
Journal:  Front Psychol       Date:  2022-06-24

3.  Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.

Authors:  Simon B Goldberg; Benjamin Shechet; Christopher R Nicholas; Chi Wing Ng; Geetanjali Deole; Zhuofan Chen; Charles L Raison
Journal:  Psychol Med       Date:  2020-11-04       Impact factor: 7.723

Review 4.  Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.

Authors:  Jacob S Aday; Alan K Davis; Cayla M Mitzkovitz; Emily K Bloesch; Christopher C Davoli
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-05

Review 5.  Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice.

Authors:  Jake E Payne; Richard Chambers; Paul Liknaitzky
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-16

6.  Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.

Authors:  Calvin Ly; Alexandra C Greb; Maxemiliano V Vargas; Whitney C Duim; Ana Cristina G Grodzki; Pamela J Lein; David E Olson
Journal:  ACS Pharmacol Transl Sci       Date:  2020-09-11

7.  Associations between lifetime classic psychedelic use and markers of physical health.

Authors:  Otto Simonsson; James D Sexton; Peter S Hendricks
Journal:  J Psychopharmacol       Date:  2021-03-09       Impact factor: 4.153

8.  Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Authors:  N L Mason; K P C Kuypers; J T Reckweg; F Müller; D H Y Tse; B Da Rios; S W Toennes; P Stiers; A Feilding; J G Ramaekers
Journal:  Transl Psychiatry       Date:  2021-04-08       Impact factor: 6.222

9.  Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use.

Authors:  Alexander M Sherwood; Romain Claveau; Rafael Lancelotta; Kristi W Kaylo; Kelsey Lenoch
Journal:  ACS Omega       Date:  2020-12-02

10.  Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Authors:  Joseph M Peill; Katie E Trinci; Hannes Kettner; Lea J Mertens; Leor Roseman; Christopher Timmermann; Fernando E Rosas; Taylor Lyons; Robin L Carhart-Harris
Journal:  J Psychopharmacol       Date:  2022-01-05       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.